• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Protalix BioTherapeutics

Protalix BioTherapeutics

Protalix BioTherapeutics Inc PLX

Last Price$1.64Day Change (%)3.14%
Open Price$1.62Day Change ($)0.05
Day Range1.62–1.6852-Week Range1.53–3.33

As of Fri 7/31/2015 5:03:00 PM | USD

  1. CollPlant Names Shomrat Shurtz Senior Director of Business Development

    CollPlant Names Shomrat Shurtz Senior Director of Business Development

  2. Research and Markets: Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Pipeline Review, H1 2015 - 39 Companies & 45 Drug Profiles

    Research and Markets: Plaque Psoriasis (Psoriasis Vulgaris) Therapeutics Pipeline Review, H1 2015 - 39 Companies & 45 Drug Profiles

  3. Research and Markets: Critical Limb Ischemia Therapeutics Pipeline Review, H1 2015 - 18 Companies & 28 Drug Profiles

    Research and Markets: Critical Limb Ischemia Therapeutics Pipeline Review, H1 2015 - 18 Companies & 28 Drug Profiles

  4. Research and Markets: Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Pipeline Review, H1 2015 - 24 Companies & 15 Drug Profiles

    Research and Markets: Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics Pipeline Review, H1 2015 - 24 Companies & 15 Drug Profiles

  5. Research and Markets: Gastrointestinal Stromal Tumor (GIST) Therapeutics Pipeline Review, H1 2015 - 21 Companies & 28 Drug Profiles

    Research and Markets: Gastrointestinal Stromal Tumor (GIST) Therapeutics Pipeline Review, H1 2015 - 21 Companies & 28 Drug Profiles

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.